Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance.
- NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_assertion description "[The ERK1/2 (extracellular signal-regulated kinase 1 and 2) pathway, comprising the protein kinases RAF (v-raf-1 murine leukemia viral oncogene homolog 1), MEK1/2 (mitogen-activated protein kinase or ERK kinase 1 and 2) and ERK1/2 is frequently de-regulated in human cancers, due to mutations in RAS or BRAF (v-raf-1 murine leukemia viral oncogene homolog B1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance.
- NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_assertion evidence source_evidence_literature NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance.
- NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_assertion SIO_000772 22562245 NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance.
- NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_assertion wasDerivedFrom befree-20140225 NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance.
- NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_assertion wasGeneratedBy ECO_0000203 NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP811085.RAU2MMebox22gweYF15Oj6cP__nB25THj-vEdC4qpsrJo130_provenance.